|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
IL47062A
(en)
|
1975-04-10 |
1979-07-25 |
Yeda Res & Dev |
Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
|
|
US4190328A
(en)
|
1978-12-01 |
1980-02-26 |
Levine Robert A |
Process for detection of blood-borne parasites
|
|
US4665077A
(en)
|
1979-03-19 |
1987-05-12 |
The Upjohn Company |
Method for treating rejection of organ or skin grafts with 6-aryl pyrimidine compounds
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
IL85746A
(en)
|
1988-03-15 |
1994-05-30 |
Yeda Res & Dev |
Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases
|
|
FI891226A7
(fi)
|
1988-04-28 |
1989-10-29 |
The Board Of Trustees Of The Leland |
Anti-T-solun reseptorideterminantit autoimmuunisairauden hoitoon
|
|
AU636110B2
(en)
|
1988-06-08 |
1993-04-22 |
Nichols Institute Diagnostics |
Assays utilizing sensitizer-induced production of detectable signal
|
|
WO1990008187A1
(en)
|
1989-01-19 |
1990-07-26 |
Dana Farber Cancer Institute |
Soluble two domain cd2 protein
|
|
EP0463101B2
(en)
|
1989-03-21 |
2003-03-19 |
The Immune Response Corporation |
Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
|
|
ATE161850T1
(de)
|
1989-07-19 |
1998-01-15 |
Connetics Corp |
T-zell-rezeptor-peptide als heilmittel für autoimmune und bösartige krankheiten
|
|
AU630497B2
(en)
|
1989-09-05 |
1992-10-29 |
Immunex Corporation |
Tumor necrosis factor-alpha and -beta receptors
|
|
US5170801A
(en)
*
|
1990-10-02 |
1992-12-15 |
Glaxo Inc. |
Medical capsule device actuated by radio-frequency (rf) signal
|
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
|
US5314805A
(en)
|
1991-10-28 |
1994-05-24 |
Molecular Probes, Inc. |
Dual-fluorescence cell viability assay using ethidium homodimer and calcein AM
|
|
AU701578B2
(en)
|
1992-08-21 |
1999-02-04 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
KR100232688B1
(ko)
|
1992-09-15 |
1999-12-01 |
스코트 쥐. 홀퀴스트 |
종양 괴사 인자 길항제를 함유하는 tnf-의존성 염증 치료용 제약 조성물
|
|
US6180403B1
(en)
|
1999-10-28 |
2001-01-30 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression
|
|
US5705398A
(en)
|
1994-03-02 |
1998-01-06 |
The Scripps Research Institute |
Methods for identifying inhibitors of LPS-mediated LBP binding
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
DK0929578T3
(da)
|
1996-02-09 |
2003-08-25 |
Abbott Lab Bermuda Ltd |
Humane antistoffer, der binder human TNFalfa
|
|
US5763602A
(en)
|
1996-10-01 |
1998-06-09 |
Li; Ying-Syi |
Methods of syntheses of phthalocyanine compounds
|
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
|
US6046319A
(en)
|
1997-10-22 |
2000-04-04 |
University Technologies International, Inc. |
Antisense oligodeoxynucleotides regulating expression of TNF-α
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AU2679899A
(en)
|
1998-02-18 |
1999-09-06 |
Dade Behring Inc. |
Chemiluminescent compositions for use in detection of multiple analytes
|
|
US6228642B1
(en)
|
1998-10-05 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
|
|
US6080580A
(en)
|
1998-10-05 |
2000-06-27 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
|
|
US8636648B2
(en)
*
|
1999-03-01 |
2014-01-28 |
West View Research, Llc |
Endoscopic smart probe
|
|
US6331530B1
(en)
|
1999-07-13 |
2001-12-18 |
The Trustees Of Columbia University In The City Of New York |
Hydrophilic carrier for photosensitizers that cleaves when they catalyze the formation of singlet oxygen
|
|
US6703248B1
(en)
|
1999-12-15 |
2004-03-09 |
Dade Behring Marburg Gmbh |
Particles for diagnostic and therapeutic use
|
|
EP1359845B1
(en)
*
|
2001-01-22 |
2012-11-14 |
Spectrum Dynamics LLC |
Ingestible device
|
|
US20050227935A1
(en)
|
2001-05-18 |
2005-10-13 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)
|
|
US7160258B2
(en)
*
|
2001-06-26 |
2007-01-09 |
Entrack, Inc. |
Capsule and method for treating or diagnosing the intestinal tract
|
|
US6949347B2
(en)
|
2002-03-05 |
2005-09-27 |
Aclara Biosciences, Inc. |
Multiplex analysis using membrane-bound sensitizers
|
|
DE60334378D1
(de)
|
2002-07-05 |
2010-11-11 |
Temrel Ltd |
Zusammensetzung zur kontrollierten wirkstoffabgabe
|
|
US20040219142A1
(en)
|
2002-07-19 |
2004-11-04 |
Abbott Laboratories S.A. |
Treatment of skin and nail disorders using TNFalpha inhibitors
|
|
TWI250312B
(en)
|
2002-10-11 |
2006-03-01 |
Delta Electronics Inc |
Illumination system with multiple lamps
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
WO2006006948A2
(en)
|
2002-11-14 |
2006-01-19 |
Dharmacon, Inc. |
METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
|
|
US7977471B2
(en)
|
2002-11-14 |
2011-07-12 |
Dharmacon, Inc. |
siRNA targeting TNFα
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
US7402398B2
(en)
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
|
AU2004275804A1
(en)
|
2003-09-23 |
2005-04-07 |
Light Sciences Oncology, Inc. |
Conjugates for photodynamic therapy
|
|
DE602005021475D1
(de)
|
2004-03-26 |
2010-07-08 |
Lek Pharmaceuticals |
Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
DE102004059613A1
(de)
*
|
2004-12-10 |
2006-06-14 |
Liedtke, Rainer K., Dr. |
Zusammensetzung und Methode einer topischen Therapie von Neurodermitis
|
|
JP2008532568A
(ja)
*
|
2005-01-18 |
2008-08-21 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
電子制御されるカプセル
|
|
KR20130108481A
(ko)
|
2005-08-19 |
2013-10-02 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
WO2007148238A1
(en)
*
|
2006-06-20 |
2007-12-27 |
Koninklijke Philips Electronics, N.V. |
Electronic capsule for treating gastrointestinal disease
|
|
JP2009541018A
(ja)
*
|
2006-06-23 |
2009-11-26 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
薬剤投与システム
|
|
ES2439994T3
(es)
|
2006-08-28 |
2014-01-27 |
Kyowa Hakko Kirin Co., Ltd. |
Anticuerpos antagonistas monoclonales humanos específicos de LIGHT humano
|
|
WO2011004395A1
(en)
|
2009-07-06 |
2011-01-13 |
Intas Biopharmaceuticals Limited |
Microemulsion formulation for biologicals
|
|
JP6030956B2
(ja)
*
|
2009-08-05 |
2016-11-24 |
テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド |
胃腸管の異常の診断に使える情報を提供する方法と機器
|
|
US9415004B2
(en)
*
|
2010-12-23 |
2016-08-16 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
|
US8907081B2
(en)
|
2011-05-27 |
2014-12-09 |
Sharp Laboratories Of America, Inc. |
Long wavelength absorbing porphyrin photosensitizers for dye-sensitized solar cells
|
|
US8884006B2
(en)
|
2011-09-19 |
2014-11-11 |
University Of Puerto Rico |
Small-molecule inhibitors of Rac1 in metastatic breast cancer
|
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
|
FR2986432B1
(fr)
|
2012-02-06 |
2014-03-14 |
Univ Lille Ii Droit & Sante |
Proteines 28kda gst provenant de schistosomes pour leur utilisation dans le traitement des maladies inflammatoires auto-immunes engendrant une reponse de type th1 et/ou th17
|
|
US20130315913A1
(en)
|
2012-03-26 |
2013-11-28 |
Sanofi |
Anti-light antibody therapy for inflammatory bowel disease
|
|
EP2970399B1
(en)
*
|
2013-03-13 |
2021-11-10 |
Emory University |
Protein particles comprising disulfide crosslinkers and uses related thereto
|
|
JP6461787B2
(ja)
|
2013-04-12 |
2019-01-30 |
国立大学法人京都大学 |
肺胞上皮前駆細胞の誘導方法
|
|
SG11201509371XA
(en)
|
2013-05-24 |
2015-12-30 |
Nestec Sa |
Pathway specific markers for diagnosing irritable bowel syndrome
|
|
PL226431B1
(pl)
|
2013-08-23 |
2017-07-31 |
Inst Biochemii I Biofizyki Polskiej Akademii Nauk |
Cząsteczka miRNA do zastosowania do wytwarzania leku do zmniejszania reakcji zapalnej lub zapobiegania zwiększaniu się reakcji zapalnej organizmu
|
|
EP3750590B8
(en)
*
|
2013-09-26 |
2025-08-13 |
BT Bidco, Inc. |
Delivery capsule with threshold release
|
|
GB201319792D0
(en)
*
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
|
MX388027B
(es)
|
2013-11-13 |
2025-03-19 |
Pfizer |
Anticuerpos específicos para el ligando 1a tipo factor de necrosis tumoral y composiciones y usos de los mismos.
|
|
WO2015099749A1
(en)
*
|
2013-12-27 |
2015-07-02 |
Capso Vision Inc. |
Capsule camera device with multi-spectral light sources
|
|
BR112016015140A2
(pt)
|
2013-12-30 |
2018-01-23 |
Epimab Biotherapeutics Inc. |
imunoglobulina com fabs in-tandem e usos das mesmas
|
|
WO2015112575A1
(en)
|
2014-01-22 |
2015-07-30 |
The Board Of Regents Of The University Of Nebraska |
Gastrointestinal sensor implantation system
|
|
US10955422B2
(en)
*
|
2014-02-27 |
2021-03-23 |
Biogen Ma, Inc. |
Method of assessing risk of PML
|
|
RU2697851C2
(ru)
|
2014-08-13 |
2019-08-21 |
Седарс-Синаи Медикал Сентер |
Антиметаногенные композиции и их применение
|
|
EP4706525A3
(en)
*
|
2014-09-25 |
2026-04-22 |
BT Bidco, Inc. |
Electromechanical pill device with localization capabilities
|
|
US9714288B2
(en)
|
2014-09-30 |
2017-07-25 |
The Regents Of The University Of California |
Antisense compounds and uses thereof
|
|
WO2016099792A1
(en)
*
|
2014-11-19 |
2016-06-23 |
Nano Pharmaceutical Laboratories Llc |
Wireless communications system integrating electronics into orally ingestible products for controlled release of active ingredients
|
|
CN104473611B
(zh)
|
2015-01-19 |
2018-01-30 |
吉林大学 |
具有超声波定位功能的胶囊内窥镜系统
|
|
KR20170122776A
(ko)
|
2015-03-06 |
2017-11-06 |
신세틱 바이오로직스, 인코퍼레이티드 |
마이크로바이옴 보호를 위한 안전하고 유효한 베타-락타마제 투약
|
|
DK3277719T3
(da)
|
2015-03-31 |
2022-05-02 |
Sorriso Pharmaceuticals Inc |
Polypeptider
|
|
ES2716900T3
(es)
*
|
2015-11-06 |
2019-06-17 |
Promise Advanced Proteomics |
Un método para cuantificar anticuerpos anti-TNF
|
|
EP3219727B1
(en)
|
2016-03-17 |
2020-12-16 |
Tillotts Pharma AG |
Anti-tnf alpha-antibodies and functional fragments thereof
|
|
JP7224917B2
(ja)
|
2016-03-31 |
2023-02-20 |
ソリッソ ファーマシューティカルズ，インク． |
組成物
|